Literature DB >> 1366236

Successful treatment of focal hepatic candidiasis with liposomal amphotericin B.

B O'Connell1, G Crotty, M T Cafferkey, R Stephens, G S McDonald, S R McCann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1366236     DOI： 10.1007/bf02942378

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  6 in total

1.  Hepatic candidiasis: an increasing problem in immunocompromised patients.

Authors:  E Haron; R Feld; P Tuffnell; B Patterson; R Hasselback; A Matlow
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

2.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

Review 3.  Hepatic candidiasis in cancer patients: the evolving picture of the syndrome.

Authors:  M Thaler; B Pastakia; T H Shawker; T O'Leary; P A Pizzo
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

4.  Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

Authors:  G Lopez-Berestein; G P Bodey; L S Frankel; K Mehta
Journal:  J Clin Oncol       Date:  1987-02       Impact factor: 44.544

5.  Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B.

Authors:  A Shirkhoda; G Lopez-Berestein; J M Holbert; M A Luna
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

Review 6.  Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients.

Authors:  L S Tashjian; J S Abramson; J E Peacock
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.